Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Actelion
Company Monitoring Page for Actelion
latest headlines for company on cafepharma
Actelion's psoriasis drug meets main goal in trial
Reuters
Tue, 12/18/12 - 12:51 pm
Tags:
Actelion
,
ponesimod
,
chronic plaque psoriasis
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
Tags:
biotech
,
M&A
,
Amarin
,
Achillion
,
ONYX Pharmaceuticals
,
Actelion
,
Elan
,
Forest Labs
,
Medivation
,
Biomarin
,
Indenix
Detailed data supports Actelion's big lung drug hope
Reuters
Wed, 10/24/12 - 12:05 pm
Tags:
Actelion
,
macitentan
,
PAH
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Mon, 10/22/12 - 12:09 pm
Tags:
Bayer
,
PAH
,
Actelion
,
Gilead
,
Riociguat
,
Tracleer
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine
,
Vectura
,
tofacitinib
,
Takeda
,
T-DM1
,
Sanofi
,
Roche
,
REGN727
,
Regeneron
,
Reata
,
QVA149
,
Pfizer
,
Odanacatib
,
Novartis
,
MorphoSys
,
Merck
,
macitentan
,
Lundbeck
,
Immunogen
,
GSK
,
GS-7977
,
Gilead
,
gantenerumab
,
Eliquis
,
darapladib
,
Bristol-Myers Squibb
,
Biogen Idec
,
BG-12
,
Bayer
,
Bardoxolone
,
Anacetrapib
,
Alpharadin
,
Algeta
,
Actelion
,
AbbVie
Actelion Raises 2012 Forecast On Reduced First-Half Costs
Bloomberg
Thu, 07/19/12 - 07:45 am
Tags:
Actelion
,
guidance
Actelion Plans To Cut 135 Jobs, Refocus Research Effort
Bloomberg
Thu, 07/12/12 - 07:30 pm
Tags:
layoffs
,
reorganization
,
Actelion
Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
Bloomberg Businessweek
Thu, 07/5/12 - 05:21 pm
Tags:
GSK
,
Sanofi
,
Actelion
,
Advair
Actelion Lung Drug Meets Main Goal in Pivotal Study
Bloomberg
Mon, 04/30/12 - 10:21 am
Tags:
Actelion
,
macitentan
,
pulmonary arterial hypertension
,
PAH
Research shows Merck's prospective flushing drug may have another use: preventing baldness
NJ.com
Thu, 03/22/12 - 11:29 am
Tags:
Merck
,
baldness
,
Actelion
Actelion Sees 2012 Profit Unchanged as Economic Crisis Hurts Drug Prices
Bloomberg
Tue, 02/14/12 - 11:04 am
Tags:
guidance
,
Actelion
Actelion Counts on ‘Make or Break’ Lung Drug
Bloomberg
Tue, 01/31/12 - 08:06 am
Tags:
Actelion
,
macitentan
Actelion Plunges After Forecasting Declining Sales in 2012
Bloomberg
Thu, 10/20/11 - 09:23 am
Tags:
guidance
,
earnings
,
Actelion
Actelion provides update on post-trial motions in Asahi Kasei litigation
Reuters
Sat, 07/30/11 - 10:17 am
Tags:
Actelion
,
Asahi Kasei
,
legal
,
lawsuits
Actelion Expects Tracleer Competition, Has Quarterly Loss
Bloomberg
Thu, 07/21/11 - 12:26 pm
Tags:
earnings
,
Tracleer
,
Actelion
Dawn of A New Sleep Drug?
WSJ Online
Tue, 07/19/11 - 11:54 am
Tags:
insomnia
,
GSK
,
Actelion
,
Sanofi
Swiss Biotech IPOs May Revive Industry Starved of Investment
Bloomberg
Thu, 07/7/11 - 10:15 pm
Tags:
IPOs
,
Roche
,
Novartis
,
Actelion
,
Molecular Partners
,
Newron Pharma
,
Switzerland
Actelion Profit Rises 10% on Payment From GlaxoSmithKline
Bloomberg
Tue, 04/19/11 - 09:44 am
Tags:
earnings
,
Actelion
Actelion Would Consider Sale at Close to Value, Reuters Says
Bloomberg
Wed, 04/13/11 - 07:51 am
Tags:
M&A
,
Actelion
Actelion board nominees deny sale is main aim
Reuters
Mon, 04/4/11 - 08:45 am
Tags:
M&A
,
Actelion
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.